467 related articles for article (PubMed ID: 25385046)
1. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
2. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes associated with L16P and T118M mutations in the membrane-embedded PMP22 protein, consequential in CMT-1A.
Bello M; Torres MJ; Méndez-Tenorio A; Correa-Basurto J
J Biomol Struct Dyn; 2017 Oct; 35(13):2880-2894. PubMed ID: 27609586
[TBL] [Abstract][Full Text] [Related]
5. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22.
Marinko JT; Wright MT; Schlebach JP; Clowes KR; Heintzman DR; Plate L; Sanders CR
J Biol Chem; 2021; 296():100719. PubMed ID: 33933451
[TBL] [Abstract][Full Text] [Related]
7. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
[TBL] [Abstract][Full Text] [Related]
8. gp78 functions downstream of Hrd1 to promote degradation of misfolded proteins of the endoplasmic reticulum.
Zhang T; Xu Y; Liu Y; Ye Y
Mol Biol Cell; 2015 Dec; 26(24):4438-50. PubMed ID: 26424800
[TBL] [Abstract][Full Text] [Related]
9. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
10. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
11. The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized.
Myers JK; Mobley CK; Sanders CR
Biochemistry; 2008 Oct; 47(40):10620-9. PubMed ID: 18795802
[TBL] [Abstract][Full Text] [Related]
12. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
13. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
14. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
15. USP19-Mediated Deubiquitination Facilitates the Stabilization of HRD1 Ubiquitin Ligase.
Harada K; Kato M; Nakamura N
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827840
[TBL] [Abstract][Full Text] [Related]
16. Peripheral endoplasmic reticulum localization of the Gp78 ubiquitin ligase activity.
St-Pierre P; Dang T; Joshi B; Nabi IR
J Cell Sci; 2012 Apr; 125(Pt 7):1727-37. PubMed ID: 22328510
[TBL] [Abstract][Full Text] [Related]
17. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
[TBL] [Abstract][Full Text] [Related]
18. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
19. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
20. The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
Park HJ; Ryu D; Parmar M; Giasson BI; McFarland NR
PLoS One; 2017; 12(9):e0184262. PubMed ID: 28877262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
